Kate Beecher Matthews (she/her)
banner
kate-beecher.bsky.social
Kate Beecher Matthews (she/her)
@kate-beecher.bsky.social
🇦🇺🧠🔬👩‍🔬🐕🐕🐈‍⬛🐈🌻🌈
Reposted by Kate Beecher Matthews (she/her)
🎉 Exciting news! Our paper "ROS1 IHC as a potential predictive biomarker in breast cancer" has been chosen as the cover feature for this issue of @Histo_Journal ! 🧬💥

To read our paper ➡️ doi.org/10.1111/his....

#BreastCancer #Pathology #Histopathology #UQCCR
July 7, 2025 at 6:27 AM
Reposted by Kate Beecher Matthews (she/her)
Lobular #breastcancer is under-recognised & under-researched — we're working to change that.

Support our #research at UQ & the Brisbane Breast Bank to improve detection & treatment💗

🔗 www.justgiving.com/campaign/bri...

#LobularBreastCancer #ILC #WomensHealth #UQCCR
Brisbane Breast Bank - Lobular breast cancer research
The Brisbane Breast Bank is a repository for donated breast cancer samples. The researchers in our team study a range of different types of breast cancers, including lobular breast cancer.
www.justgiving.com
June 27, 2025 at 12:21 AM
Reposted by Kate Beecher Matthews (she/her)
LBCA is offering travel scholarship grants for advocates interested in Invasive Lobular Carcinoma (ILC) education to attend the 2025 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 9-12, 2025. Deadline to apply is Monday, July 21st: tinyurl.com/LBCATravelGr...
June 24, 2025 at 11:56 PM
Reposted by Kate Beecher Matthews (she/her)
Our lab just loves working extra hard on a Friday 🧑‍🔬🙌😂!!
@breast-lab.bsky.social @amymccart.bsky.social @kate-beecher.bsky.social
June 20, 2025 at 3:32 AM
Reposted by Kate Beecher Matthews (she/her)
🎤A/Prof @amymccart.bsky.social officially opened the Herston Breast Cancer Research Network at #UQCCR
An exciting step forward in strengthening collaboration across research, clinical care, & innovation in #breastcancer💗🧬#HerstonResearch #Collaboration #TranslationalResearch
June 12, 2025 at 6:44 AM
Reposted by Kate Beecher Matthews (she/her)
📢Exciting Phase 1 BrCa trial @ Herston
Prof Sudha Rao & Dr Michelle Nottage — exploring the barriers & enablers to early-phase trials — from both the research & clinical perspectives💡🧪#benchtobedside #BreastCancerResearch #ClinicalTrials #Phase1Trials #Translational
June 12, 2025 at 6:46 AM
Reposted by Kate Beecher Matthews (she/her)
A/Prof Pete Simpson shared a fantastic overview of #UQCCR’s research capacity, highlighting our strengths in #translational science, clinical partnerships & emerging technologies. A great reminder of the depth of expertise driving impact across disciplines🔬🤝 #Biobank
June 12, 2025 at 6:47 AM
Reposted by Kate Beecher Matthews (she/her)
🏥 Phase 1 PCL breast scafford implementation one year follow-up📍
Prof Owen Ung from the #MNHHS Breast Cancer Institute with a vision for an integrated #breastcancer ecosystem across #Herston
🔬#BreastCancerCare #Collaboration #PatientCentredResearch
June 12, 2025 at 6:47 AM
Reposted by Kate Beecher Matthews (she/her)
🔍Prof @julietfrench.bsky.social ch01 gave an insightful overview of @QIMRBerghofer’s #breastcancer research capacity, showcasing strengths in genomics, multi-omics, AI precision oncology & TME research. Exciting to see the synergy across #Herston’s research ecosystem!💡🧬 #Collaboration
June 12, 2025 at 6:48 AM
Reposted by Kate Beecher Matthews (she/her)
🏥Dr Melissa Eastgate from RBWH Cancer Care Services highlighted the clinical strengths & research collaborations driving #breastcancer care at #Herston.
A powerful reminder of the critical link between research & real-world patient impact💗 #ClinicalImpact #TranslationalResearch
June 12, 2025 at 6:49 AM
Reposted by Kate Beecher Matthews (she/her)
💬 In the Q&A panel, everyone emphasised the need for clear strategy & shared goals to drive meaningful collaboration across the #Herston #breastcancer ecosystem. Stronger together—for better science and better outcomes💡🤝
Thank you to all the speakers 👏
June 12, 2025 at 6:49 AM
Reposted by Kate Beecher Matthews (she/her)
Kicking off DNA extraction for the ctDNA lobular breast cancer project — part of Tivya's PhD! Can’t wait to see what secrets these tumours are hiding…

#LabLife #LobularBreastCancer #ctDNA #PhDLife #TeamScience #UQCCR
May 16, 2025 at 12:54 AM
Reposted by Kate Beecher Matthews (she/her)
Reposted by Kate Beecher Matthews (she/her)
🍎Breast cancer... and apples?🍏@amymccart.bsky.social nailed her @pintofscienceAU talk with the perfect mix of science & analogies — a full house at Easy Times! Huge thanks to @MehershadW for hosting such a fun and insightful night! 👏🧠💥 #Pint2025 #UQCCR
May 21, 2025 at 7:57 AM
Reposted by Kate Beecher Matthews (she/her)
Exciting news – @amymccart.bsky.social is speaking at @pintofscienceAU! 🎤👏

🗓️ Tues 20 May
📍 Easy Times Brewing Co, Brisbane
🧬 Cuts, Cures & the Stories Behind the Scars

Science, beer & good vibes – let’s go support her! 🍺

🎟️👉 pintofscience.com.au/event/cuts-c...
#pintofscience #PintAU25
April 10, 2025 at 5:05 AM
Reposted by Kate Beecher Matthews (she/her)
Big crowd at the #10xOmiX event in Brisbane to hear from the best local scientists on how @10xgenomics.bsky.social is helping them advance their research projects.
April 4, 2025 at 2:21 AM
Reposted by Kate Beecher Matthews (she/her)
📝 Latest Publication Alert! 📝

Commentary: Peer reviewer fatigue, or peer reviewer refusal?

Kate Beecher Matthews & Joshua Wang

doi.org/10.1080/0898...

#PeerReview
#ScholarlyPublishing
#ResearchIntegrity
Peer reviewer fatigue, or peer reviewer refusal?
Peer review processes are slowing. Existing literature and policies conceptualize this stagnation in peer review as a result of academic fatigue. Here, we instead examine an under-researched factor...
doi.org
February 18, 2025 at 2:28 PM
🚨New Commentary Alert!🚨

Peer review is slowing—but is academic fatigue the only reason?🤔Are these refusals a necessary stand or a threat to scholarly publishing? ⤵️

🔗https://www.tandfonline.com/doi/full/10.1080/08989621.2025.2463977

#PeerReview #AcademicPublishing @accountabilityair.bsky.social
February 20, 2025 at 2:42 AM